)
)
Revenio Investor Relations Material
Latest events
Q3 2024
Revenio
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Revenio Group
Access all reports
Segment Data
Access more data
Net sales by
Geography
North America
Other Europe
Finland
Other
Expenses by
Financials
Revenio Group Oyj designs, manufactures, and sells medical instruments for the early detection of glaucoma, diabetic retinopathy, and macular degeneration. The company's vision is to create a world without blindness. It offers ophthalmology and optometry products like the Topcon Refractometer, the Diagnolyzer FT, the Diabetoscan DR/A1C+, and the XDM-400 Cell Health Analyzer; cell health analysis systems for measuring cellular health of skin cells, bone marrow cells and dental pulp cells; as well as other medical devices that measure the mechanical stress of tissues by stethoscopy (examination of tissues via a stethoscope) and laser Doppler flowmetry (measures blood flow in tissue), and enables quantitative analysis of renal function. The company is based in Vantaa, Finland.
Key slides for Revenio Group
Q3 2024
Revenio Group
Q4 2023
Revenio Group
Latest articles
)
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
REG1V
Country
🇫🇮 Finland